IL6 and familial dilated cardiomyopathy: Abdelrahman et al. (2021), found that elevated levels of advanced glycation end-products (AGEs), IL-6, TNF-α, and insulin can be used for early prediction of DCM, as observed from a study in Egypt (Abdelrahman et al., 2021).